Updated menopause, hormone replacement, heart health guidelines released

Note: This is a summary of information produced by the source under Full Article below. All questions should be directed to the original news source.

October 31, 2022

The guidelines, informing the care of perimenopausal and post-menopausal woman in Canada are backed by data to help physicians know when to prescribe menopausal hormone therapy and when it might not be worth potential risks. Post-menopause, women are at a higher risk for a number of health conditions, including cardiovascular disease. The updated guidelines state that menopausal hormone therapy is the most effective treatment for the relief of menopause symptoms. Researchers found that short-term menopausal hormone therapy didn’t come with increased cardiovascular risk when appropriately prescribed to women who were not at a high risk for heart problems.
Related:
Hormonothérapie et santé du coeur: de nouvelles directives cliniques essentielles pour les médecins, infirmières, pharmaciens et autres professionnels de la santé - SOGC

Full article link